share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Stefanelli Jill

SEC ·  Nov 21, 2023 07:10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.